Released May 7, 2015, after the close
10-Q filed May 7, 2015, 37 days after period end · 0001104659-15-035555
Q1 2015 · 10-Q
Revenue—
Net Income-$7.88M-$7.88M N/M vs Q1 2014N/M vs Q4 2014
EPS Diluted-$0.38-$0.38 N/M vs Q1 2014N/M vs Q4 2014
Operating Income-$7,324,000N/M
Operating Cash Flow-$6,375,000N/M
Free Cash Flowderived-$6,827,000N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Revenue | — | — | $472.00K | $418.00K |
| Net Income | -$7.88M | -$6.98M | -$3.55M | -$3.23M |
| EPS Diluted | -$0.38 | -$0.34 | -$2.92 | -$3.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Fate Therapeutics Inc · CIK 1434316 · Engraved from SEC EDGAR